Paper42442016
Neonatal gene therapy with AAV2/8-LSPhGAA improves hypertrophic cardiomyopathy in the Gaac.1826dupA knock-in murine model.
Kan SH and 8 others. Mol Genet Metab, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Neonatal gene therapy with AAV2/8-LSPhGAA improves hypertrophic cardiomyopathy in the Gaac.1826dupA knock-in murine model. Papers, record 42442016. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42442016
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Neonatal gene therapy with AAV2/8-LSPhGAA improves hypertrophic cardiomyopathy in the Gaac.1826dupA knock-in murine model.
- PubMed
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cardiomyopathy, Hypertrophic | Major topic |
| Genetic Therapy | Major topic |
| alpha-Glucosidases | Major topic |
| Glycogen Storage Disease Type II | Major topic |
| Animals | |
| Dependovirus | |
| Mice | |
| Disease Models, Animal | |
| Gene Knock-In Techniques | |
| Humans | |
| Gene Therapy Agents | |
| Mice, Inbred C57BL | |
| Male | |
| Muscle, Skeletal | |
| Animals, Newborn | |
| Female | |
| Glycogen | |
| Myocardium |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| R01 AR079223 | NIAMS NIH HHS | United States | R01AR079223 | PubMed |
Source NIH RePORTER
References40
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 15585405 | Replacing acid alpha-glucosidase in Pompe disease: recombinant and transgenic enzymes are equipotent, but neither completely clears glycogen from type II muscle fibers. | Mol Ther | 2005 | https://conductscience.org/library/papers/15585405 | PubMed |
| 2 | 4236721 | Hurler and Hunter syndromes: mutual correction of the defect in cultured fibroblasts. | Science | 1968 | https://conductscience.org/library/papers/4236721 | PubMed |
| 3 | 41622854 | Longitudinal characterization of Gaac.1826dupA mice reveals the cardiac, myopathic and biochemical phenotypes of Pompe disease. | Dis Model Mech | 2026 | https://conductscience.org/library/papers/41622854 | PubMed |
| 4 | 16005263 | Evasion of immune responses to introduced human acid alpha-glucosidase by liver-restricted expression in glycogen storage disease type II. | Mol Ther | 2005 | https://conductscience.org/library/papers/16005263 | PubMed |
| 5 | 22743772 | Fiji: an open-source platform for biological-image analysis. | Nat Methods | 2012 | https://conductscience.org/library/papers/22743772 | PubMed |
| 6 | 17151339 | Recombinant human acid [alpha]-glucosidase: major clinical benefits in infantile-onset Pompe disease. | Neurology | 2007 | https://conductscience.org/library/papers/17151339 | PubMed |
| 7 | 10097136 | Sustained correction of bleeding disorder in hemophilia B mice by gene therapy. | Proc Natl Acad Sci U S A | 1999 | https://conductscience.org/library/papers/10097136 | PubMed |
| 8 | 38346589 | Treatment of infantile-onset Pompe disease in a rat model with muscle-directed AAV gene therapy. | Mol Metab | 2024 | https://conductscience.org/library/papers/38346589 | PubMed |
| 9 | 36517654 | CRISPR-mediated generation and characterization of a Gaa homozygous c.1935C>A (p.D645E) Pompe disease knock-in mouse model recapitulating human infantile onset-Pompe disease. | Sci Rep | 2022 | https://conductscience.org/library/papers/36517654 | PubMed |
| 10 | 29295737 | Immunomodulatory, liver depot gene therapy for Pompe disease. | Cell Immunol | 2019 | https://conductscience.org/library/papers/29295737 | PubMed |
| 11 | 32587263 | CRISPR-Cas9 generated Pompe knock-in murine model exhibits early-onset hypertrophic cardiomyopathy and skeletal muscle weakness. | Sci Rep | 2020 | https://conductscience.org/library/papers/32587263 | PubMed |
| 12 | 28344998 | Low-Dose Liver-Targeted Gene Therapy for Pompe Disease Enhances Therapeutic Efficacy of ERT via Immune Tolerance Induction. | Mol Ther Methods Clin Dev | 2017 | https://conductscience.org/library/papers/28344998 | PubMed |
| 13 | 15922959 | Correction of glycogen storage disease type II by an adeno-associated virus vector containing a muscle-specific promoter. | Mol Ther | 2005 | https://conductscience.org/library/papers/15922959 | PubMed |
| 14 | 9384603 | Generalized glycogen storage and cardiomegaly in a knockout mouse model of Pompe disease. | Hum Mol Genet | 1998 | https://conductscience.org/library/papers/9384603 | PubMed |
| 15 | 9668092 | Targeted disruption of the acid alpha-glucosidase gene in mice causes an illness with critical features of both infantile and adult human glycogen storage disease type II. | J Biol Chem | 1998 | https://conductscience.org/library/papers/9668092 | PubMed |
| 16 | 23601496 | B-Cell depletion and immunomodulation before initiation of enzyme replacement therapy blocks the immune response to acid alpha-glucosidase in infantile-onset Pompe disease. | J Pediatr | 2013 | https://conductscience.org/library/papers/23601496 | PubMed |
| 17 | 21508954 | Retro-orbital injections in mice. | Lab Anim (NY) | 2011 | https://conductscience.org/library/papers/21508954 | PubMed |
| 18 | 13954110 | alpha-Glucosidase deficiency in generalized glycogenstorage disease (Pompe's disease). | Biochem J | 1963 | https://conductscience.org/library/papers/13954110 | PubMed |
| 19 | 31392200 | Liver depot gene therapy for Pompe disease. | Ann Transl Med | 2019 | https://conductscience.org/library/papers/31392200 | PubMed |
| 20 | 12192090 | Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy. | Proc Natl Acad Sci U S A | 2002 | https://conductscience.org/library/papers/12192090 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42442016
GET https://conductscience.org/api/papers/v1/42442016/references?page=2